184 related articles for article (PubMed ID: 11368557)
41. Hop (Humulus lupulus L.) Extract and 6-Prenylnaringenin Induce P450 1A1 Catalyzed Estrogen 2-Hydroxylation.
Wang S; Dunlap TL; Howell CE; Mbachu OC; Rue EA; Phansalkar R; Chen SN; Pauli GF; Dietz BM; Bolton JL
Chem Res Toxicol; 2016 Jul; 29(7):1142-50. PubMed ID: 27269377
[TBL] [Abstract][Full Text] [Related]
42. Cytochrome P450 1B1: a target for inhibition in anticarcinogenesis strategies.
Peter Guengerich F; Chun YJ; Kim D; Gillam EM; Shimada T
Mutat Res; 2003; 523-524():173-82. PubMed ID: 12628515
[TBL] [Abstract][Full Text] [Related]
43. The K-region trans-8,9-diol does not significantly contribute as an intermediate in the metabolic activation of dibenzo[a,l]pyrene to DNA-binding metabolites by human cytochrome P450 1A1 or 1B1.
Luch A; Kishiyama S; Seidel A; Doehmer J; Greim H; Baird WM
Cancer Res; 1999 Sep; 59(18):4603-9. PubMed ID: 10493514
[TBL] [Abstract][Full Text] [Related]
44. Cytochrome P450 1A1 and 1B1 in human blood lymphocytes are not suitable as biomarkers of exposure to dioxin-like compounds: polymorphisms and interindividual variation in expression and inducibility.
van Duursen MB; Sanderson JT; van den Berg M
Toxicol Sci; 2005 May; 85(1):703-12. PubMed ID: 15659568
[TBL] [Abstract][Full Text] [Related]
45. Enzymatic characterization of in vitro-expressed Baikal seal cytochrome P450 (CYP) 1A1, 1A2, and 1B1: implication of low metabolic potential of CYP1A2 uniquely evolved in aquatic mammals.
Iwata H; Yamaguchi K; Takeshita Y; Kubota A; Hirakawa S; Isobe T; Hirano M; Kim EY
Aquat Toxicol; 2015 May; 162():138-151. PubMed ID: 25814058
[TBL] [Abstract][Full Text] [Related]
46. Metabolism of benzo[a]pyrene and benzo[a]pyrene-7,8-diol by human cytochrome P450 1B1.
Kim JH; Stansbury KH; Walker NJ; Trush MA; Strickland PT; Sutter TR
Carcinogenesis; 1998 Oct; 19(10):1847-53. PubMed ID: 9806168
[TBL] [Abstract][Full Text] [Related]
47. Bioactivation of diesel exhaust particle extracts and their major nitrated polycyclic aromatic hydrocarbon components, 1-nitropyrene and dinitropyrenes, by human cytochromes P450 1A1, 1A2, and 1B1.
Yamazaki H; Hatanaka N; Kizu R; Hayakawa K; Shimada N; Guengerich FP; Nakajima M; Yokoi T
Mutat Res; 2000 Dec; 472(1-2):129-38. PubMed ID: 11113705
[TBL] [Abstract][Full Text] [Related]
48. Induction of cytochrome P450 1B1 and catechol estrogen metabolism in ACHN human renal adenocarcinoma cells.
Spink DC; Spink BC; Cao JQ; Gierthy JF; Hayes CL; Li Y; Sutter TR
J Steroid Biochem Mol Biol; 1997 Jun; 62(2-3):223-32. PubMed ID: 9393958
[TBL] [Abstract][Full Text] [Related]
49. Induction of cytochrome P450 1B1 in MDA-MB-231 human breast cancer cells by non-ortho-substituted polychlorinated biphenyls.
Spink BC; Pang S; Pentecost BT; Spink DC
Toxicol In Vitro; 2002 Dec; 16(6):695-704. PubMed ID: 12423652
[TBL] [Abstract][Full Text] [Related]
50. Catalytic properties of polymorphic human cytochrome P450 1B1 variants.
Shimada T; Watanabe J; Kawajiri K; Sutter TR; Guengerich FP; Gillam EM; Inoue K
Carcinogenesis; 1999 Aug; 20(8):1607-13. PubMed ID: 10426814
[TBL] [Abstract][Full Text] [Related]
51. Equine estrogens differentially prevent neuronal cell death induced by glutamate.
Bhavnani BR; Berco M; Binkley J
J Soc Gynecol Investig; 2003 Jul; 10(5):302-8. PubMed ID: 12853093
[TBL] [Abstract][Full Text] [Related]
52. Characterization of CYP1B1 and CYP1A1 expression in human mammary epithelial cells: role of the aryl hydrocarbon receptor in polycyclic aromatic hydrocarbon metabolism.
Larsen MC; Angus WG; Brake PB; Eltom SE; Sukow KA; Jefcoate CR
Cancer Res; 1998 Jun; 58(11):2366-74. PubMed ID: 9622076
[TBL] [Abstract][Full Text] [Related]
53. A metabolite of equine estrogens, 4-hydroxyequilenin, induces DNA damage and apoptosis in breast cancer cell lines.
Chen Y; Liu X; Pisha E; Constantinou AI; Hua Y; Shen L; van Breemen RB; Elguindi EC; Blond SY; Zhang F; Bolton JL
Chem Res Toxicol; 2000 May; 13(5):342-50. PubMed ID: 10813650
[TBL] [Abstract][Full Text] [Related]
54. Molecular Cloning, Tissue Distribution, and Functional Characterization of Marmoset Cytochrome P450 1A1, 1A2, and 1B1.
Uehara S; Uno Y; Inoue T; Sasaki E; Yamazaki H
Drug Metab Dispos; 2016 Jan; 44(1):8-15. PubMed ID: 26502772
[TBL] [Abstract][Full Text] [Related]
55. Preferential induction of cytochrome P450 1A1 over cytochrome P450 1B1 in human breast epithelial cells following exposure to quercetin.
Mense SM; Chhabra J; Bhat HK
J Steroid Biochem Mol Biol; 2008 May; 110(1-2):157-62. PubMed ID: 18456490
[TBL] [Abstract][Full Text] [Related]
56. The human cytochrome P450 1A1 mRNA is rapidly degraded in HepG2 cells.
Lekas P; Tin KL; Lee C; Prokipcak RD
Arch Biochem Biophys; 2000 Dec; 384(2):311-8. PubMed ID: 11368318
[TBL] [Abstract][Full Text] [Related]
57. Quantitative analysis of constitutive and 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced cytochrome P450 1B1 expression in human lymphocytes.
Spencer DL; Masten SA; Lanier KM; Yang X; Grassman JA; Miller CR; Sutter TR; Lucier GW; Walker NJ
Cancer Epidemiol Biomarkers Prev; 1999 Feb; 8(2):139-46. PubMed ID: 10067811
[TBL] [Abstract][Full Text] [Related]
58. Inhibition of human cytochrome P450 1A1-, 1A2-, and 1B1-mediated activation of procarcinogens to genotoxic metabolites by polycyclic aromatic hydrocarbons.
Shimada T; Guengerich FP
Chem Res Toxicol; 2006 Feb; 19(2):288-94. PubMed ID: 16485905
[TBL] [Abstract][Full Text] [Related]
59. SULT1A1 catalyzes 2-methoxyestradiol sulfonation in MCF-7 breast cancer cells.
Spink BC; Katz BH; Hussain MM; Pang S; Connor SP; Aldous KM; Gierthy JF; Spink DC
Carcinogenesis; 2000 Nov; 21(11):1947-57. PubMed ID: 11062153
[TBL] [Abstract][Full Text] [Related]
60. Expression of CYP1B1 but not CYP1A1 by primary cultured human mammary stromal fibroblasts constitutively and in response to dioxin exposure: role of the Ah receptor.
Eltom SE; Larsen MC; Jefcoate CR
Carcinogenesis; 1998 Aug; 19(8):1437-44. PubMed ID: 9744540
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
